Skip to main content
Toggle main menu visibility
Menu
Join
Sign In
Communities
Membership
Events
Publications
Learning & Careers
AIChE Home
About
Contact AIChE
Leadership
Events
Communities
Membership
Learning & Careers
Publications
Careers at AIChE
Equity, Diversity, Inclusion
Giving
Students
Young Professionals
Operating councils
Local Sections
Committees
Awards
Communities
Membership
Events
Publications
Learning & Careers
Toggle site search visibility
Sign In
Join
Breadcrumb
Home
Publications
Proceedings
2017 Metabolic Engineering Summit
General Submissions
ME as an Enabling Technology for Driving Innovation
Impact of yeast lipid pathway engineering and bioprocess strategy on cellular physiology and lipid content
2011 Annual Meeting
Session: QbD In Dry Powder Inhaler Development : Multifaceted Powder Characterization for Product Development
Chair
Freeman, T.
, Freeman Technology
Co-Chair
Cruz, C.
, Eli Lilly and Company
Presentations
03:15 PM
Welcoming Remarks
03:20 PM
(752a) Quality by Design for DPIs -A Regulatory Perspective
03:50 PM
(752b) QbD In Dry Powder Inhaler Development
04:20 PM
(752c) The Influence of Crystals, Particles and Powders On the Performance of Dry Powder Inhalers
04:50 PM
(752d) A Dry Powder Inhaler, a User Interface or a Formulation Interface? Designing for Quality Amidst Competing Requirements
05:20 PM
Panel Discussion
